|
|
Article: 'Molecular Therapeutics' Prove Their Mettle In Clinical Trials.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BioWorld International Correspondent
TORONTO - Understanding of the molecular mechanisms that control the growth and survival of tumor cells has generated a broad range of novel targets, and after many years of research the first generation of so-called "molecular therapeutics" aimed at these targets have recently reached the clinic.
This is a significant step in the evolution of cancer drugs, and has the potential to provide a powerful new armamentarium for clinical oncologists, Tilman Oltersdorf, director of molecular biology at Idun Pharmaceuticals Inc., told attendees of the Biotechnology Industry Organization's International Biotechnology Convention ...